The Evolving Future of PCSK9 Inhibitors
Robert S. RosensonZena and Michael A. Wiener Cardiovascular Institute, Marie-Josee and Henry R. Kravis Center for Cardiovascular Health, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: [email protected]Robert A. HegeleDepartment of Medicine and Robarts Research Institute, Schulich School of Medicine, Western University, London, Ontario, CanadaSergio FazioOregon Health & Science University, Knight Cardiovascular Institute, Center for Preventive Cardiology, Portland, OregonChristopher P. CannonCardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
2018en
ABI
Аннотация
Аннотация мавжуд эмас.
Идентификаторлар
Иқтибослар ва манбалар
4 та иқтибос0 та фойдаланилган манба